Evaluation of selected acute phase proteins in patients with metabolic syndrome;Ocena stȩżenia wybranych białek ostrej fazy u chorych na zespół metaboliczny

Polski Merkuriusz Lekarski

Volumn 21, Issue 121, 2006, Pages 12-14

  Bogdański, Paweł ^a   Chyrek, Robert ^a   Pupek Musialik, Danuta ^a   Jabłecka, Anna ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

Inflammation; Metabolic syndrome

Indexed keywords

ACUTE PHASE PROTEIN; ALPHA 1 ANTICHYMOTRYPSIN; ALPHA 2 MACROGLOBULIN; C REACTIVE PROTEIN; CERULOPLASMIN; HAPTOGLOBIN; OROSOMUCOID; TRANSFERRIN;

ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; IMMUNOELECTROPHORESIS; METABOLIC SYNDROME X; WAIST CIRCUMFERENCE; ADULT; ATHEROSCLEROSIS; FEMALE; MALE; METABOLISM; MIDDLE AGED; OBESITY; REFERENCE VALUE;

ACUTE-PHASE PROTEINS; ADULT; ALPHA 1-ANTICHYMOTRYPSIN; ALPHA-MACROGLOBULINS; ATHEROSCLEROSIS; C-REACTIVE PROTEIN; FEMALE; HAPTOGLOBINS; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; OROSOMUCOID; REFERENCE VALUES; TRANSFERRIN;

EID: 33747117347     PISSN: 14269686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Albert K., Balkau B., Standl E. i wsp.: Type 2 Diabetes and the Metabolic Syndrome in Europe. Eur. Heart J., 2005, 7, suppl. D, 3-5.
2. Bogdański P., Pupek-Musialik D., Dytfeld J. i wsp.: Ocena wybranych wykładników stanu zapalnego u chorych z naddciśnieniem tȩtniczym i klinicznymi cechami zespołu metabolicznego. Nadciśnienie Tȩtnicze, 2005, 9, 3, 194-199.
3. Chae C., Lee R., Rifai N. i wsp.: Blood Pressure and Inflammation in Apparently Healthy. Men. Hypertension, 2001, 38, 399.
4. Czech A., Szczeklik-Kumala Z.: Kliniczne i biochemiczne skladniki zespolu metabolicznego w reprezentatywnej próbie populacji Warszawy. Med. Metabol., 2002, IV/4, suppl., 26.
5. Dandona P., Aljada A., Chaudhuri A. i wsp.: Metabolic syndrome: a comprehensive perspective based on interactions between obesity, diabetes, and inflammation. Circulation, 2005, 22, 111(11), 1448-1454.
6. Elkind M., Cheng J., Boden-Albala B. i wsp.: Tumor necrosis factor receptor levels are associated with carotid atherosclerosis. Stroke, 2002, 33 (1), 31-37.
7. Flegal K., Carroll M., Ogden C. i wsp.: Prevalence and trends in obesity among US adults 1999-2000. JAMA, 2002, 288, 1723-1727.
8. Hotamisligil G., Amer P., Caro J. i wsp.: Increased adipose expression of tumor necrosis factor-α in human obesity and insulin resistance. J. Clin. Invest, 1995, 95, 2409-2415.
9. Hu G., Qiao Q., Tuomilehto J. i wsp.: Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in nondiabetic European men and women. Arch. Intern. Med., 2004, 164(10), 1066-1076.
10. Kern P., Ranganathan S., Li C. i wsp.: Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. Am. J. Physiol., 2001, 280, 745-751.
11. Kern P., Saghizadeh M., Ong J. i wsp.: The expression of tumor necrosis factor in human adipose tissue. Regulation of obesity, weight loss, and relationship to lipoprotein lipase. J. Clin. Invest., 1996, 97, 1111-1116.
12. Kobayashi K.: Adipokines: therapeutic targets for metabolic syndrome. Curr. Drug Targets, 2005, 6(4), 525-529.
13. Koj A.: Biologiczne funkcje białek ostrej fazy. Diagn. Lab., 1987, 23, 191-208.
14. Kralisch S., Klein J., Bluher M. i wsp.: Therapeutic perspectives of adipocytokines. Expert Opin Pharmacother, 2005, 6(6), 863-872.
15. st International Congress on "Prediabetes" and the Metabolic Syndrome. Berlin, Germany, April 13-16, 2005. Book of Abstracts, 6.
16. Nesto R.: The relation of insulin resistance syndromes to risk of cardiovascular disease. Rev. Cardiovasc. Med., 2003, 4, 11-18.
17. Pickup J., Mattock M., Chusney G. I wsp.: NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X. Diabetologia, 1997, 40, 1286-1292.
18. Ridker P.: Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation, 2003, 107(3), 363-369.
19. Ross R.: Atherosclerosis - an inflammatory disease. N. Engl. J. Med., 1999, 2, 115-126.
20. Rywik S., Paja̧k A., Broda G. i wsp.: Czȩstość wystȩpowania nadwagi i otytości w wybranych populacjach Polski - Pol-MONICA Bis Project. Medycyna Metaboliczna, 2003, 2, 8-15.
21. Savage D., Petersen K., Shulman G.: Mechanisms of insulin resistance in humans and possible links with inflammation. Hypertension, 2005, 45(5), 828-833.
22. Trayhurn P., Wood I.: Signalling role of adipose tissue: adipokines and inflammation in obesity. Biochem. Soc. Trans., 2005, 33 (5), 1078-1081.
23. Vallance P., Collier J., Bhagat K,: Infection, inflammation, and infarction: does acute endothelial dysfunction provide a link? Lancet, 1997, 349 (9062), 1391-1392.